Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome

Table 1

Effects of rituximab on motor performance: a comparison of OMS evaluation scale scores before and after treatment.

Scale items	Before treatment*	After treatment*
(1) Walking, side-to-side imbalance	3	1
(2) Walking, front-to-back imbalance	3	0
(3) Walking, wide base	3	1
(4) Instability while standing (feet apart)	3	0
(5) Difficulty achieving standing position	2	0
(6) Truncal instability while sitting	2	0
(7) Targeting difficulty	3	1
(8) Difficulty grasping with one hand	1	1
(9) Difficulty with pincer grasp	2	0
(10) Abnormal eye movements while tracking (fixation)	2	0
(11) Abnormal eye movements while resting	2	0
(12) Speech abnormality (dysarthria)	2	2

∗Scores were from 0 to 3 (0: normal, 1: mild, 2: moderate, 3: severe).